People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gatc Health Corp | — | Healthtech | Series B | $52.4M | $5.6M | 2023 |
| Cure Pharmaceutical Holding Corp. | — | Pharmaceuticals | Series B | $31.5M | $342.9M | 2018 |
| CURE PHARMACEUTICAL Corp | — | Pharmaceuticals | Series A | $9.9M | $10.0M | 2012 |
Robert Davidson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Davidson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edward Maliski | 2 | 2 |
| Mark Udell | 2 | 2 |
| Gene Salkind | 1 | 5 |
| Alex Katz | 1 | 5 |
| John Bell | 1 | 5 |
| Jeff Moses | 1 | 5 |
| Dennis Locke | 1 | 4 |
| CHARLES BERMAN | 1 | 3 |
| Rahul Gupta | 1 | 3 |
| John Stroh | 1 | 2 |
| Gerald DeCiccio | 1 | 2 |
| Lin Yu | 1 | 2 |
| Michael Manahan | 1 | 2 |
| Gerry Martin | 1 | 2 |
| Lauren Chung | 1 | 2 |
| JOSH HELD | 1 | 2 |
| Rob Davidson | 1 | 2 |
| Alan Einstein | 1 | 1 |
| Wayne Nasby | 1 | 1 |
| Vic Branstetter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.